咳嗽变异性哮喘的特异性免疫治疗

Specific Immunotherapy of Cough Variant Asthma

目的：探讨咳嗽变异性哮喘的特异性免疫治疗效果。方法：对92例咳嗽变异性哮喘（CVA）患者根据变应原种类不同进行特异性免疫治疗,并根据CVA评分结果进行分析。结果：92例患者中有效78例,占84.8%,无效9例,占9.8%,复发5例,占5.4%。有效的78例患者免疫治疗时间持续3年以上,无效及复发的患者免疫治疗时间少于2~4年。结论：咳嗽变异性哮喘的特异性免疫治疗效果理想,其特异性免疫治疗维持时间是治疗CVA的关键。

@@@@[ABSTRCT]Objective：To study treatment effects of Specific immunotherapy for cough variant asthma. Methods：92 cases of cough variant asthma patients were treated with Specific immunotherapy according to the type of allergen,then evaluate the effects according to the CVA score. Results：78 patients received significant effects in 92 cases, occupying 84.8%, treatment effects of 9 patients are ineffective in 92 cases, occupying 9.8%,5 patients relapsed, occupying 5.4%, The continual treat time of 78 patients received significant effects is over 3 years, the continual treat time of those ineffective or relapsed patients is less 2~4 years. Conclusion：The treatment effect of Specific immunotherapy for cough variant asthma is significant, but the continual treat time is the most important for CVA .